{"entity":{"id":"nct06034197","kind":"trial","name":"Fluorescent Probe VGT-309 to ID Cancerous Colorectal Lesions During Augmented Colonoscopy","aka":[],"tldr":"A phase 1 trial of Abenacianine run by Stephan Rogalla, terminated.","summary":"Fluorescent Probe VGT-309 to ID Cancerous Colorectal Lesions During Augmented Colonoscopy is a phase 1 interventional study registered as NCT06034197 by Stephan Rogalla, with 9 participants enrolled, started 2024-02-07. Conditions recorded: Colorectal Cancer. Interventions recorded: VGT-309.","status":"historic","asOf":"2026-11-03","links":[{"label":"ClinicalTrials.gov NCT06034197","url":"https://clinicaltrials.gov/study/NCT06034197"}],"tags":["pipeline","ctgov-ingest"],"related":[],"cancers":["colorectal"],"sections":[],"technologies":[],"targets":[],"drugs":["abenacianine"],"companies":["vergent-bioscience"],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":[],"nct":"NCT06034197","phase":"1","setting":"Pilot Open Label Study to Determine the Safety and Efficacy of Fluorescent Probe, VGT-309, to Identify Cancerous Colorectal Lesions During White-Light and Fluorescence Augmented Colonoscopy","sponsor":"Stephan Rogalla","enrolled":9,"enrolledBasis":"registry","outcomes":[]},"route":"/trials/nct06034197/","neighbours":{"cancer":[{"id":"colorectal","kind":"cancer","name":"Colorectal cancer","route":"/cancers/colorectal/"}],"drug":[{"id":"abenacianine","kind":"drug","name":"Abenacianine","route":"/drugs/abenacianine/"}],"company":[{"id":"vergent-bioscience","kind":"company","name":"Vergent Bioscience","route":"/companies/vergent-bioscience/"}]}}